RDHL logo

RedHill Biopharma (RDHL) Cash From Investing

Annual CFI

$4000.00
-$8.30 M-99.95%

December 31, 2023


Summary


Performance

RDHL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRDHLcash flowmetrics:

Quarterly CFI

N/A

June 1, 2024


Summary


Performance

RDHL Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRDHLcash flowmetrics:

TTM CFI

N/A

June 1, 2024


Summary


Performance

RDHL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRDHLcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

RDHL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%--
3 y3 years+100.0%--
5 y5 years-99.9%--

RDHL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%+100.0%
5 y5-year-100.0%+100.0%
alltimeall time-100.0%+100.0%

RedHill Biopharma Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2023
$4000.00(-100.0%)
-
-
Jun 2023
-
-$7000.00(<-9900.0%)
-$29.00 K(-84.3%)
Mar 2023
-
$0.00(0.0%)
-$185.00 K(-102.2%)
Dec 2022
$8.30 M(-202.0%)
$0.00(-100.0%)
$8.30 M(-29.6%)
Sep 2022
-
-$22.00 K(-86.5%)
$11.80 M(+257.5%)
Jun 2022
-
-$163.00 K(-101.9%)
$3.30 M(-8350.0%)
Mar 2022
-
$8.49 M(+142.7%)
-$40.00 K(-99.5%)
Dec 2021
-$8.14 M(-77.2%)
$3.50 M(-141.0%)
-$8.14 M(+115.0%)
Sep 2021
-
-$8.52 M(+143.2%)
-$3.79 M(-164.1%)
Jun 2021
-
-$3.50 M(-1005.2%)
$5.91 M(-115.1%)
Mar 2021
-
$387.00 K(-95.1%)
-$39.26 M(+10.1%)
Dec 2020
-$35.65 M(-790.3%)
$7.85 M(+568.7%)
-$35.65 M(-26.3%)
Sep 2020
-
$1.17 M(-102.4%)
-$48.40 M(+27.9%)
Jun 2020
-
-$48.67 M(-1316.8%)
-$37.83 M(-607.7%)
Mar 2020
-
$4.00 M(-181.7%)
$7.45 M(+44.3%)
Dec 2019
$5.16 M(-3.5%)
-$4.90 M(-141.7%)
$5.16 M(-49.5%)
Sep 2019
-
$11.74 M(-446.3%)
$10.23 M(-389.0%)
Jun 2019
-
-$3.39 M(-298.0%)
-$3.54 M(-156.2%)
Mar 2019
-
$1.71 M(+878.3%)
$6.30 M(+17.8%)
Dec 2018
$5.35 M(-128.8%)
$175.00 K(-108.6%)
$5.35 M(-238.9%)
Sep 2018
-
-$2.04 M(-131.6%)
-$3.85 M(-131.8%)
Jun 2018
-
$6.46 M(+749.5%)
$12.10 M(+1461.5%)
Mar 2018
-
$760.00 K(-108.4%)
$775.00 K(-104.2%)
Dec 2017
-$18.58 M
-$9.03 M(-164.9%)
-$18.58 M(-258.0%)
DateAnnualQuarterlyTTM
Sep 2017
-
$13.91 M(-385.7%)
$11.76 M(+37.9%)
Jun 2017
-
-$4.87 M(-73.8%)
$8.53 M(-18.6%)
Mar 2017
-
-$18.60 M(-187.2%)
$10.48 M(-57.2%)
Dec 2016
$24.47 M(-215.5%)
$21.32 M(+99.5%)
$24.47 M(-244.8%)
Sep 2016
-
$10.68 M(-465.3%)
-$16.90 M(-32.8%)
Jun 2016
-
-$2.92 M(-36.4%)
-$25.14 M(+34.3%)
Mar 2016
-
-$4.60 M(-77.1%)
-$18.72 M(-11.7%)
Dec 2015
-$21.19 M(+18.6%)
-$20.06 M(-919.1%)
-$21.19 M(+1689.9%)
Sep 2015
-
$2.45 M(-29.9%)
-$1.18 M(-74.6%)
Jun 2015
-
$3.50 M(-149.4%)
-$4.66 M(-81.3%)
Mar 2015
-
-$7.08 M(>+9900.0%)
-$24.91 M(+39.5%)
Dec 2014
-$17.86 M(-1682.1%)
-$51.00 K(-95.0%)
-$17.86 M(+1.8%)
Sep 2014
-
-$1.02 M(-93.9%)
-$17.54 M(+4.9%)
Jun 2014
-
-$16.76 M(>+9900.0%)
-$16.72 M(-3117.7%)
Mar 2014
-
-$25.00 K(-109.2%)
$554.00 K(-50.9%)
Dec 2013
$1.13 M(-62.1%)
$272.00 K(-234.0%)
$1.13 M(-66.9%)
Sep 2013
-
-$203.00 K(-139.8%)
$3.41 M(-64.5%)
Jun 2013
-
$510.00 K(-7.3%)
$9.61 M(+6.8%)
Mar 2013
-
$550.00 K(-78.5%)
$9.00 M(+202.3%)
Dec 2012
$2.98 M(-162.5%)
$2.56 M(-57.4%)
$2.98 M(+605.5%)
Sep 2012
-
$5.99 M(-6094.0%)
$422.00 K(-107.6%)
Jun 2012
-
-$100.00 K(-98.2%)
-$5.57 M(+1.8%)
Mar 2012
-
-$5.47 M
-$5.47 M
Dec 2011
-$4.77 M(+369.2%)
-
-
Dec 2010
-$1.02 M
-
-

FAQ

  • What is RedHill Biopharma annual cash flow from investing activities?
  • What is the all time high annual CFI for RedHill Biopharma?
  • What is RedHill Biopharma annual CFI year-on-year change?
  • What is the all time high quarterly CFI for RedHill Biopharma?
  • What is the all time high TTM CFI for RedHill Biopharma?

What is RedHill Biopharma annual cash flow from investing activities?

The current annual CFI of RDHL is $4000.00

What is the all time high annual CFI for RedHill Biopharma?

RedHill Biopharma all-time high annual cash flow from investing activities is $24.47 M

What is RedHill Biopharma annual CFI year-on-year change?

Over the past year, RDHL annual cash flow from investing activities has changed by -$8.30 M (-99.95%)

What is the all time high quarterly CFI for RedHill Biopharma?

RedHill Biopharma all-time high quarterly cash flow from investing activities is $21.32 M

What is the all time high TTM CFI for RedHill Biopharma?

RedHill Biopharma all-time high TTM cash flow from investing activities is $24.47 M